老年人停用苯二氮卓类药物的长期影响:对抑郁症状的潜在改善。

IF 2.8 3区 医学 Q3 GERIATRICS & GERONTOLOGY Aging & Mental Health Pub Date : 2024-12-01 Epub Date: 2024-07-02 DOI:10.1080/13607863.2024.2372473
Arnaud Allary, Virginie Proulx-Tremblay, Claude Bélanger, Carol Hudon, Kieron O'Connor, Pasquale Roberge, Helen-Maria Vasiliadis, Caroline Desrosiers, Diana Cruz-Santiago, Sébastien Grenier
{"title":"老年人停用苯二氮卓类药物的长期影响:对抑郁症状的潜在改善。","authors":"Arnaud Allary, Virginie Proulx-Tremblay, Claude Bélanger, Carol Hudon, Kieron O'Connor, Pasquale Roberge, Helen-Maria Vasiliadis, Caroline Desrosiers, Diana Cruz-Santiago, Sébastien Grenier","doi":"10.1080/13607863.2024.2372473","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To examine how change in benzodiazepine (BZD) use is linked to changes in depressive symptoms intensity, worry intensity, and sleep quality over 16 months.</p><p><strong>Method: </strong>Data come from a larger randomised controlled trial (RCT) named the 'Programme d'Aide du Succès au SEvrage (PASSE-60+)' study (NCT02281175). Seventy-three participants age 60 years and older took part in a 4-month discontinuation programme and were assessed four times over 16 months. Change in BZD use was defined as the difference in reported mg/day between two assessments. Control variables were RCT discontinuation group; BZD use at T1; and either depressive symptoms, worry intensity, or sleep quality at T1. Hierarchical multiple regressions were used to analyse data.</p><p><strong>Results: </strong>In the short term, right after the discontinuation programme, sleep quality worsened with lower BZD use. This link was no longer significant at the 3- and 12-month follow-up. In the long term, depressive symptoms lowered with lower BZD use. No change was found in worry intensity in relation to BZD use at all measurement times.</p><p><strong>Conclusion: </strong>Discontinuation may improve depressive symptoms. Our study also questions the long-term effectiveness of BZD use, since long-term discontinuation was not linked with change in worry intensity and sleep quality.</p>","PeriodicalId":55546,"journal":{"name":"Aging & Mental Health","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-term effects of benzodiazepine discontinuation among older adults: potential improvements on depressive symptoms.\",\"authors\":\"Arnaud Allary, Virginie Proulx-Tremblay, Claude Bélanger, Carol Hudon, Kieron O'Connor, Pasquale Roberge, Helen-Maria Vasiliadis, Caroline Desrosiers, Diana Cruz-Santiago, Sébastien Grenier\",\"doi\":\"10.1080/13607863.2024.2372473\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To examine how change in benzodiazepine (BZD) use is linked to changes in depressive symptoms intensity, worry intensity, and sleep quality over 16 months.</p><p><strong>Method: </strong>Data come from a larger randomised controlled trial (RCT) named the 'Programme d'Aide du Succès au SEvrage (PASSE-60+)' study (NCT02281175). Seventy-three participants age 60 years and older took part in a 4-month discontinuation programme and were assessed four times over 16 months. Change in BZD use was defined as the difference in reported mg/day between two assessments. Control variables were RCT discontinuation group; BZD use at T1; and either depressive symptoms, worry intensity, or sleep quality at T1. Hierarchical multiple regressions were used to analyse data.</p><p><strong>Results: </strong>In the short term, right after the discontinuation programme, sleep quality worsened with lower BZD use. This link was no longer significant at the 3- and 12-month follow-up. In the long term, depressive symptoms lowered with lower BZD use. No change was found in worry intensity in relation to BZD use at all measurement times.</p><p><strong>Conclusion: </strong>Discontinuation may improve depressive symptoms. Our study also questions the long-term effectiveness of BZD use, since long-term discontinuation was not linked with change in worry intensity and sleep quality.</p>\",\"PeriodicalId\":55546,\"journal\":{\"name\":\"Aging & Mental Health\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Aging & Mental Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/13607863.2024.2372473\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aging & Mental Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13607863.2024.2372473","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:研究苯二氮卓(BZD)使用量的变化与抑郁症状强度、担忧强度和睡眠质量在 16 个月内的变化有何联系:研究16个月内苯二氮卓(BZD)使用量的变化如何与抑郁症状强度、担忧强度和睡眠质量的变化相关联:数据来自一项名为 "Programme d'Aide du Succès au SEvrage (PASSE-60+)"(NCT02281175)的大型随机对照试验(RCT)。73 名 60 岁及以上的参与者参加了为期 4 个月的停药计划,并在 16 个月内接受了 4 次评估。BZD使用量的变化被定义为两次评估之间报告的毫克/天的差异。对照变量包括:RCT停药组;T1时的BZD使用情况;T1时的抑郁症状、担忧强度或睡眠质量。数据分析采用层次多元回归法:结果:在短期内,即停药计划结束后,睡眠质量会随着 BZD 使用量的减少而恶化。在 3 个月和 12 个月的随访中,这种联系不再明显。从长期来看,抑郁症状随着 BZD 使用量的减少而减轻。在所有测量时间内,均未发现担忧强度与使用BZD有关:结论:停药可改善抑郁症状。我们的研究还对使用 BZD 的长期有效性提出了质疑,因为长期停用 BZD 与担忧强度和睡眠质量的变化无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Long-term effects of benzodiazepine discontinuation among older adults: potential improvements on depressive symptoms.

Objectives: To examine how change in benzodiazepine (BZD) use is linked to changes in depressive symptoms intensity, worry intensity, and sleep quality over 16 months.

Method: Data come from a larger randomised controlled trial (RCT) named the 'Programme d'Aide du Succès au SEvrage (PASSE-60+)' study (NCT02281175). Seventy-three participants age 60 years and older took part in a 4-month discontinuation programme and were assessed four times over 16 months. Change in BZD use was defined as the difference in reported mg/day between two assessments. Control variables were RCT discontinuation group; BZD use at T1; and either depressive symptoms, worry intensity, or sleep quality at T1. Hierarchical multiple regressions were used to analyse data.

Results: In the short term, right after the discontinuation programme, sleep quality worsened with lower BZD use. This link was no longer significant at the 3- and 12-month follow-up. In the long term, depressive symptoms lowered with lower BZD use. No change was found in worry intensity in relation to BZD use at all measurement times.

Conclusion: Discontinuation may improve depressive symptoms. Our study also questions the long-term effectiveness of BZD use, since long-term discontinuation was not linked with change in worry intensity and sleep quality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Aging & Mental Health
Aging & Mental Health 医学-精神病学
CiteScore
7.00
自引率
2.90%
发文量
176
审稿时长
4-8 weeks
期刊介绍: Aging & Mental Health provides a leading international forum for the rapidly expanding field which investigates the relationship between the aging process and mental health. The journal addresses the mental changes associated with normal and abnormal or pathological aging, as well as the psychological and psychiatric problems of the aging population. The journal also has a strong commitment to interdisciplinary and innovative approaches that explore new topics and methods. Aging & Mental Health covers the biological, psychological and social aspects of aging as they relate to mental health. In particular it encourages an integrated approach for examining various biopsychosocial processes and etiological factors associated with psychological changes in the elderly. It also emphasizes the various strategies, therapies and services which may be directed at improving the mental health of the elderly and their families. In this way the journal promotes a strong alliance among the theoretical, experimental and applied sciences across a range of issues affecting mental health and aging. The emphasis of the journal is on rigorous quantitative, and qualitative, research and, high quality innovative studies on emerging topics.
期刊最新文献
Examining mental health and autonomic function as putative mediators of the relationship between sleep and trajectories of cognitive function: findings from the Irish longitudinal study on ageing (TILDA). Exploring the associations between structural and functional aspects of social relationships and cognition in very old age. Sensory impairments and depressive symptoms in Europe: a cross-national cohort study. Co-occurrence of depressive and anxious symptoms and their influence on self-rated health: a national representative survey among Chinese older adults. Association between loneliness and mild cognitive impairment in older adults: a meta-analysis of longitudinal studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1